StockNews.com Upgrades USANA Health Sciences (NYSE:USNA) to "Strong-Buy"

StockNews.com upgraded shares of USANA Health Sciences (NYSE:USNA - Free Report) from a buy rating to a strong-buy rating in a report issued on Saturday morning.

Separately, DA Davidson upgraded USANA Health Sciences to a "hold" rating in a research report on Friday, December 20th.

USANA Health Sciences Stock Down 0.7 %

Shares of USNA traded down $0.25 on Friday, reaching $35.69. The stock had a trading volume of 85,667 shares, compared to its average volume of 84,504. USANA Health Sciences has a twelve month low of $31.44 and a twelve month high of $54.81. The firm has a market capitalization of $680.25 million, a PE ratio of 12.61, a PEG ratio of 1.25 and a beta of 0.89. The firm has a 50-day moving average of $37.88 and a 200 day moving average of $39.94.

USANA Health Sciences (NYSE:USNA - Get Free Report) last released its quarterly earnings results on Tuesday, October 22nd. The company reported $0.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.49 by $0.07. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The business had revenue of $200.22 million during the quarter, compared to the consensus estimate of $208.45 million. During the same quarter in the previous year, the company posted $0.59 EPS. On average, sell-side analysts anticipate that USANA Health Sciences will post 2.45 earnings per share for the current fiscal year.

Insider Transactions at USANA Health Sciences

In related news, Director Gilbert A. Fuller sold 675 shares of the business's stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $37.71, for a total value of $25,454.25. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.33% of the company's stock.

Institutional Trading of USANA Health Sciences

A number of institutional investors and hedge funds have recently modified their holdings of USNA. Safe Harbor Fiduciary LLC acquired a new stake in shares of USANA Health Sciences during the 3rd quarter worth approximately $30,000. KBC Group NV grew its stake in USANA Health Sciences by 96.6% during the 3rd quarter. KBC Group NV now owns 1,056 shares of the company's stock worth $40,000 after buying an additional 519 shares during the last quarter. Centiva Capital LP bought a new position in USANA Health Sciences during the 3rd quarter worth $213,000. BOKF NA increased its position in USANA Health Sciences by 99.4% in the second quarter. BOKF NA now owns 5,526 shares of the company's stock worth $250,000 after buying an additional 2,755 shares during the period. Finally, Quest Partners LLC bought a new stake in USANA Health Sciences in the third quarter valued at $250,000. 54.25% of the stock is owned by institutional investors and hedge funds.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.